{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-035853","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2026-09-08T12:35:36+00:00","discovered_at":"2026-09-08T12:40:02.356200+00:00","generated_at":"2026-09-08T12:40:09.178357+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"PDS Biotech raises up to $22.55M in PIPE led by Nant; Soon-Shiong to join board","bullets":["PIPE raises up to $22.55M: $11.55M initial closing at $0.2825/unit, plus $11M milestone (Nant $10M, AB Group $1M) upon Phase 3 protocol submission.","Nant Capital led; Dr. Patrick Soon-Shiong to join board; Nant gets right to designate 2 directors while owning ≥15%.","Proceeds to repay debt and fund development; PDS0301 Phase 2 data in MSS/pMMR mCRC showed 80% survival at 24 months.","Company grants NantWorks 1-year exclusive option to negotiate license for PDS0101; board expands from 6 to 8.","Common warrants exercisable at $0.22/share for 1 year; pre-funded warrants at $0.00033; 19.9% beneficial ownership cap."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-035853","json":"https://secwatch.observer/filing/0001140361-26-035853.json","markdown":"https://secwatch.observer/filing/0001140361-26-035853.md","text":"https://secwatch.observer/filing/0001140361-26-035853.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126035853/0001140361-26-035853-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126035853/ef20081705_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T12:40:09.178357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}